Table 4 Subgroup analyses of UA levels between severe and non-severe malaria.
Subgroup analyses | P value | Hedges’ g (95% CI) | I2 (%) | Number of studies |
|---|---|---|---|---|
Publication years | ||||
2010–2023 | 0.01 | 3.87 (0.87–6.87) | 98.95 | 5 |
2000–2009 | N/A | N/A | N/A | 1 |
Study design | ||||
Cross-sectional study | 0.08 | 4.00 (− 0.44 to 8.44) | 99.09 | 4 |
Cohort study | 0.05 | 2.49 (0.02–4.97) | 98.11 | 2 |
Continent | ||||
Africa | < 0.01 | 2.68 (1.19–4.17) | 94.68 | 3 |
Asia | 0.18 | 4.34 (− 1.98 to 10.67) | 99.38 | 3 |
Age group | ||||
Children | < 0.01 | 2.68 (1.19–4.17) | 94.68 | 3 |
Adults | 0.18 | 4.34 (− 1.98 to 10.67) | 99.38 | 3 |
Plasmodium species | ||||
P. falciparum | 0.18 | 1.55 (− 0.71 to 3.80) | 98.02 | 4 |
P. vivax | N/A | N/A | N/A | 1 |
P. falciparum, P. vivax, mixed infections | N/A | N/A | N/A | 1 |
Diagnostic method for malaria | ||||
Microscopy | 0.18 | 1.55 (− 0.71 to 3.80) | 98.02 | 4 |
Microscopy/RDT | 0.23 | 7.51 (− 4.85 to 19.86) | 99.58 | 2 |
Types of blood samples | ||||
Serum | 0.03 | 4.23 (0.40–8.05) | 99.19 | 4 |
Plasma | 0.01 | 1.97 (0.44–3.49) | 89.35 | 2 |